Skip to main content

Table 2 Virus titers (TCID 50 */50 μl) 48 h post infection without or in presence of anti-CAR (RmcB), anti-DAF (BRIC 216), or both

From: Study of Coxsackie B viruses interactions with Coxsackie Adenovirus receptor and Decay-Accelerating Factor using Human CaCo-2 cell line

Isolate Control (No Ab) +BRIC216 + RcmB RcmB + BRIC216
Nancy 107.5 103 103 102.5
Rec (B3/B4) 108 104 103.7 102
B3-37335 107.3 107 103 102
B3-523-21 107.3 103.6 103.5 102
B3-02 106.6 103.9 103.3 102
B4N 107 107 104 102
B4-37428 106.6 106 103.3 103
B4 JVB 107.3 107 104 102.7
B4-0612 105.3 105 103.7 102
B4-07 105.3 105 103.5 102
B5-37534 107 103 103 102
B5-2003 108 104.9 103 102
B5-99 106.33 106 103 102
B5-2000 107.3 107 104 102
B6-041 105.9 105 103.5 102
B2-37222 106.3 106 104 102.5
B2N 106 106 103.5 102.5
B2-0610 M 105.3 105 103 102
B2-2000 106.3 106 104 102.7
B1-032 107.6 103.9 103 103
B1-0609 106.3 106 103 102
B1-0807 107.6 104 103 102
  1. (*) TCID50: 50% Tissue Culture Infective Dose.
  2. Ab: antibodies.